Number of Shares
16,153.00
Current Holdings Value*
£2.31 Mil
% of Portfolio
1.14%
Total Estimate Gain
£351,193.74
% of Total Estimate Gain
10.38%

NYLI WMC International Research Equity Fund's AstraZeneca PLC Holding Summary

As of 2025-04-30, NYLI WMC International Research Equity Fund held 16,153.00 shares of AstraZeneca PLC(LSE:AZN), totaling £2.31 Mil. This investment constitutes 1.14% of their stock portfolio, and NYLI WMC International Research Equity Fund now holds 0% of the outstanding AstraZeneca PLC(LSE:AZN) stock.

The initial trade took place in 2021Q4. And since then NYLI WMC International Research Equity Fund has made 7 purchases of LSE:AZN, at an average price of £94.50, for a total of 35,807.00 shares. In addition, there have been 7 sales at an average price of £105.44 for 19,654.00 shares. Based on historical transaction data and LSE:AZN's current price of £102.94, NYLI WMC International Research Equity Fund's estimated gain on his LSE:AZN holdings is £351,193.74, reflecting a 10.38% gain to date.

NYLI WMC International Research Equity Fund LSE:AZN (£102.94) Holding Chart

NYLI WMC International Research Equity Fund LSE:AZN (£102.94) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price £-/Share
Shares Sold 0 Average Price £-/Share
Current Price £0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1